The HMA Medicare team was asked to apply our subject matter expertise—and access to Medicare
claims information—to provide a fully formed picture of the reimbursement process for this new
drug formulation. Our work involved researching other precedents and the implications of those
precedents for the reimbursement of this new formulation, as well as the existing product.
Download the results and approach below.
The HMA Medicare team was asked to apply our subject matter expertise—and access to Medicare
claims information—to provide a fully formed picture of the reimbursement process for this new
drug formulation. Our work involved researching other precedents and the implications of those
precedents for the reimbursement of this new formulation, as well as the existing product.
Download the results and approach below.
Download